- Home
- RVT vs IRON Comparison
RVT vs IRON Comparison
Compare RVT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVT
- IRON
- Stock Information
- Founded
- RVT 1986
- IRON 2017
- Country
- RVT United States
- IRON United States
- Employees
- RVT N/A
- IRON N/A
- Industry
- RVT Trusts Except Educational Religious and Charitable
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- RVT Finance
- IRON Health Care
- Exchange
- RVT Nasdaq
- IRON Nasdaq
- Market Cap
- RVT 1.8B
- IRON 2.0B
- IPO Year
- RVT N/A
- IRON N/A
- Fundamental
- Price
- RVT $15.92
- IRON $60.35
- Analyst Decision
- RVT
- IRON Strong Buy
- Analyst Count
- RVT 0
- IRON 11
- Target Price
- RVT N/A
- IRON $95.73
- AVG Volume (30 Days)
- RVT 243.4K
- IRON 325.5K
- Earning Date
- RVT 01-01-0001
- IRON 08-07-2025
- Dividend Yield
- RVT 7.32%
- IRON N/A
- EPS Growth
- RVT N/A
- IRON N/A
- EPS
- RVT 2.95
- IRON N/A
- Revenue
- RVT N/A
- IRON N/A
- Revenue This Year
- RVT N/A
- IRON N/A
- Revenue Next Year
- RVT N/A
- IRON N/A
- P/E Ratio
- RVT $4.98
- IRON N/A
- Revenue Growth
- RVT N/A
- IRON N/A
- 52 Week Low
- RVT $11.85
- IRON $30.82
- 52 Week High
- RVT $14.93
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- RVT 64.08
- IRON 57.22
- Support Level
- RVT $15.34
- IRON $57.54
- Resistance Level
- RVT $15.67
- IRON $64.83
- Average True Range (ATR)
- RVT 0.22
- IRON 2.14
- MACD
- RVT 0.03
- IRON -0.19
- Stochastic Oscillator
- RVT 86.96
- IRON 46.60
About RVT Royce Value Trust Inc.
Royce Value Trust Inc is a diversified closed-end investment company. It invests in diversified sectors including consumer discretionary, consumer staples, healthcare, financial, IT, telecommunications, and materials. The company's portfolio includes common stocks, preferred stocks, corporate bonds, and repurchase agreements. The company invests in Industrials, Financials, Information Technology, Materials, Health Care, Communication Services, Real Estate and others.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.